Benefit unproven for self-administered high-flow therapy in COPD and type 1 respiratory failure
No benefit of high-flow therapy (HFT) can be derived from the available study data for patients with advanced chronic obstructive pulmonary disease (COPD) or chronic type 1 respiratory failure. It therefore remains unclear ...
Jul 20, 2021
0
2